It is expected to consist of 60 volunteers between the ages of 45-70 using three 150 mg doses of DehydraTECH-CBD, every day for the 6-week duration of the study Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription Cannabidiol November 1, 2021 Study to compare effectiveness of FDA-approved Epidiolex to DehydraTECH-CBD for reducing seizure activity Experts in respirology and neurobiology are among the talented team assembled to conduct the study, which is designed to investigate if DehydraTECH-CBD has similar or superior levels of efficacy in treating seizures as does the worlds only CBD-based seizure medication, Epidiolex Lexarias Technology Proven to Deliver Oral THC More Effectively October 13, 2021 DehydraTECH delivers equivalent quantity of oral THC three times faster: 15 minutes vs
It supports cellular activity related to muscle development, particularly through influencing satellite cell function and tissue repair processes
It helps regulate the movement of magnesium ions across cell membranes, ensuring adequate distribution and preventing abnormalities associated with magnesium imbalances
Vitamin B-6 Vitamin B-6 actives enzymes responsible for producing energy, neurotransmitters, red blood cells and white blood cells that support the immune system
A: Getting started is easy